Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US President Donald Trump. Mounjaro, manufactured by U.S. pharma giant Eli Lilly, has been the UK’s most popular weight loss jab,

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, unapproved drugs to reach consumers.

U.S. District Judge Karen Marston, of the Eastern District of Pennsylvania, allowed some misrepresentation claims to go forward but tossed design defect and medical monitoring allegations.

Several months after unveiling its direct-to-consumer NovoCare Pharmacy service with the launch of a $499 cash-pay option for a monthly supply of Wegovy, Novo Nordisk is expanding the discount to include its other GLP-1 heavyweight.

Weight-loss wonder pharmaceuticals Ozempic and Mounjaro may have a new rival to contend with as early as 2026, which is expected to have significantly fewer side effects—if not none at all. The news follows various studies indicating that the use of GLP-1 medications has exceeded 700% since 2019.

As Mounjaro doubles in price, we look at whether there’s another, cheaper way to suppress your appetite. By nutritionist

Plastic surgeon Dr Paul Banwell says he has seen a huge uptake in people requesting cosmetic procedures to correct 'Ozempic vulva'

It’s not just above the waistline where the effects of Ozempic are taking place. Hush-hush conversations online have revealed that the blockbuster weight loss medication is not just trimming the belly down.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the semaglutide.